ARMO BioSciences
Founded 2012
Redwood City, United States
1 employees
Series Unknown
Total: $167.00M
Biotechnology, Health Care +1
Redwood City, United States
1 employees
Series Unknown
Total: $167.00M
Biotechnology, Health Care +1
General Information
Get notified when ARMO BioSciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ARMO BioSciences
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About ARMO BioSciences
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
01 Jan 2018 |
| Series C | •••••• | 10 |
|
29 Aug 2017 |
| Series C | •••••• | 7 |
|
10 Feb 2016 |
| Series B | •••••• | 4 |
|
28 May 2014 |
| Series A | •••••• | 3 |
|
25 Nov 2013 |
ARMO BioSciences Alternatives & Competitors
ARMO BioSciences vs
Biothera Pharmaceuticals, Inc.
United States
Biothera Pharmaceuticals is a privately held, clinical stage immuno-oncology company developing our...
Series Unknown
51 employees
Biotechnology, Medical Devices
ARMO BioSciences vs
Surface Oncology Inc.
United States
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021
Post Ipo Equity
14 employees
Biotechnology, Health Care
ARMO BioSciences vs
Pionyr Immunotherapeutics
United States
The New Frontier of Immuno-Oncology
Corporate Round
19 employees
Biotechnology, Health and Wellness
FAQ About ARMO BioSciences
ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors. The Company’s lead product candidate, AM0010 (pegilodecakin, PEGylated Interleukin-10)...
ARMO BioSciences was founded in 2012.
ARMO BioSciences is headquartered in Redwood City, United States.
ARMO BioSciences operates in the following industries: Biotechnology, Health Care, Medical Devices.
ARMO BioSciences has approximately 1 employees.
ARMO BioSciences has completed 6 funding rounds, raising a total of $167.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to ARMO BioSciences include Biothera Pharmaceuticals, Inc., Surface Oncology Inc., Pionyr Immunotherapeutics, iTeos Therapeutics, Apollomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ARMO BioSciences and Biothera Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors ARMO BioSciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.